Wall Street analysts expect Envista Holdings Co. (NYSE:NVST) to announce $0.41 earnings per share for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Envista’s earnings, with the highest EPS estimate coming in at $0.44 and the lowest estimate coming in at $0.36. Envista reported earnings per share of $0.48 during the same quarter last year, which would suggest a negative year-over-year growth rate of 14.6%. The company is expected to announce its next quarterly earnings report on Thursday, November 4th.
According to Zacks, analysts expect that Envista will report full-year earnings of $1.96 per share for the current fiscal year, with EPS estimates ranging from $1.85 to $2.06. For the next financial year, analysts forecast that the business will post earnings of $2.11 per share, with EPS estimates ranging from $2.00 to $2.30. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow Envista.
Envista (NYSE:NVST) last released its quarterly earnings results on Tuesday, August 3rd. The company reported $0.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.09. Envista had a net margin of 10.84% and a return on equity of 9.72%.
Several research analysts have weighed in on the stock. Piper Sandler upped their price objective on shares of Envista from $45.00 to $47.00 and gave the company a “neutral” rating in a research note on Wednesday, August 4th. Morgan Stanley upped their price objective on shares of Envista from $42.00 to $46.00 and gave the company an “equal weight” rating in a research note on Friday, May 7th. Credit Suisse Group upped their price objective on shares of Envista from $49.00 to $55.00 and gave the company an “outperform” rating in a research note on Thursday, May 6th. TheStreet upgraded shares of Envista from a “d+” rating to a “c” rating in a research note on Thursday, May 13th. Finally, Zacks Investment Research upgraded shares of Envista from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective on the stock in a research note on Saturday, May 8th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Envista has an average rating of “Buy” and a consensus price target of $43.67.
In related news, SVP Jeffrey Kappler sold 1,717 shares of the company’s stock in a transaction on Friday, July 16th. The shares were sold at an average price of $42.00, for a total transaction of $72,114.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Curt W. Bludworth sold 9,207 shares of the company’s stock in a transaction on Monday, June 7th. The stock was sold at an average price of $42.36, for a total transaction of $390,008.52. Following the sale, the insider now directly owns 66,025 shares of the company’s stock, valued at $2,796,819. The disclosure for this sale can be found here. Insiders sold 40,192 shares of company stock valued at $1,750,670 over the last three months. Insiders own 0.82% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Macquarie Group Ltd. boosted its holdings in Envista by 771.4% in the 2nd quarter. Macquarie Group Ltd. now owns 4,015,893 shares of the company’s stock valued at $173,527,000 after purchasing an additional 3,555,062 shares during the period. Boston Partners boosted its holdings in Envista by 48.8% in the 2nd quarter. Boston Partners now owns 2,945,015 shares of the company’s stock valued at $127,358,000 after purchasing an additional 966,446 shares during the period. Bank of New York Mellon Corp boosted its holdings in Envista by 149.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,561,755 shares of the company’s stock valued at $67,485,000 after purchasing an additional 936,393 shares during the period. Smith Asset Management Group LP boosted its holdings in Envista by 3,606.1% in the 1st quarter. Smith Asset Management Group LP now owns 644,039 shares of the company’s stock valued at $26,291,000 after purchasing an additional 626,661 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in Envista by 4.2% in the 2nd quarter. Vanguard Group Inc. now owns 14,897,130 shares of the company’s stock valued at $643,705,000 after purchasing an additional 598,953 shares during the period.
Envista stock opened at $41.07 on Tuesday. The firm has a market cap of $6.62 billion, a price-to-earnings ratio of 23.07, a PEG ratio of 0.75 and a beta of 1.93. The company has a current ratio of 1.12, a quick ratio of 0.85 and a debt-to-equity ratio of 0.23. The company has a 50 day moving average of $42.22. Envista has a twelve month low of $22.51 and a twelve month high of $46.52.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company’s Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.
Recommended Story: Why does a company issue an IPO?
Get a free copy of the Zacks research report on Envista (NVST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in Envista right now?
Before you consider Envista, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Envista wasn’t on the list.
While Envista currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
